Robin Vinck

8PUBLICATIONS
48CO-AUTHORS
NanomaterialsInfant and child healthOrganometallic chemistryBiologically active moleculesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 12, 2025
Engineered mesoporous silica nanosystems with organotin(IV) complexes containing 1-(quinolin-8-yliminomethyl)naphthalen-2-ol ligand for cancer cell targeting.

Diana Díaz-García, Robin Vinck, Javier Álvarez-Conde

|Jan 11, 2024
A New Derivative of Retro-2 Displays Antiviral Activity against Respiratory Syncytial Virus.

Adrien Le Rouzic, Jenna Fix, Robin Vinck

|Mar 14, 2023
Structurally Simple Osmium(II) Polypyridyl Complexes as Photosensitizers for Photodynamic Therapy in the Near Infrared.

Asma Mani, Tao Feng, Albert Gandioso

|Dec 11, 2022
In Vivo Sustained Release of the Retrograde Transport Inhibitor Retro-2.1 Formulated in a Thermosensitive Hydrogel.

Robin Vinck, Laetitia Anvi Nguyen, Mathilde Munier

|Dec 08, 2022
Towards Selective Delivery of a Ruthenium(II) Polypyridyl Complex-Containing Bombesin Conjugate into Cancer Cells.

Maria J S A Silva, Robin Vinck, Youchao Wang

|Oct 29, 2021
Metallodrug Profiling against SARS-CoV-2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain-like Protease PLpro.

Maria Gil-Moles, Sebastian Türck, Uttara Basu

Pageof 2